| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $6.4B | $1.7B | $5.4B | $4.2B | $3.7B | $1.0B | $1.0B |
| Cost of Revenue | $4.9B | $5.3B | $4.2B | $3.2B | $2.8B | $3.0B | $3.1B |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.0B | $0.9B | $0.8B | $0.8B | — | — |
| Operating Income | $0.4B | $0.1B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B |
| Net Income | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $2.26 | $0.51 | $1.53 | $0.93 | $0.62 | $0.98 | $0.14 |
| EPS (Diluted) | $2.20 | $0.49 | $1.42 | $0.87 | $0.59 | $0.97 | $0.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $5.8B | $5.5B | $4.8B | $4.2B | $3.8B | $3.9B | $3.5B |
| Current Assets | $2.7B | $2.5B | $2.1B | $1.7B | $1.6B | $1.8B | $1.5B |
| Cash & Equivalents | $0.5B | $0.5B | $0.3B | $0.3B | $0.3B | $0.5B | $0.2B |
| Total Liabilities | $3.0B | $3.0B | $2.4B | $2.1B | $1.9B | $2.1B | $1.8B |
| Current Liabilities | $1.5B | $1.9B | $1.4B | $1.1B | $1.0B | $1.2B | $1.1B |
| Stockholders' Equity | $2.6B | $2.4B | $2.3B | $2.0B | $1.9B | $1.8B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.4B | $0.2B | $0.2B | $0.3B | $0.2B |
| Investing Cash Flow | $-0.3B | $-0.6B | $-0.4B | $-0.4B | $-0.2B | $-0.3B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $0.2B | $-0.0B | $0.1B | $-0.1B | $0.3B | $0.3B |